Meningococcal disease is caused by various serogroups of Neisseria meningitidis (N. meningitidis), of which groups A, B, C, W, Y account for about 95% of meningococcal disease. N. meningitidis is one of the most common causes of bacterial meningitis in the world and the only bacterium capable of generating large epidemics of meningitis.
Meningococcal disease
General Information
Transmission
Meningococcus is transmitted by aerosol or direct contact with respiratory secretions of patients or healthy human carriers.
Symptoms
Meningitis and sepsis are the major clinical features of infection with N. meningitidis. Meningitis frequently presents with fever, headache and neck stiffness, and is often accompanied by other symptoms, such as altered mental status, nausea, vomiting and photophobia. Meningococcal sepsis is characterised by fever and a purpuric rash, often accompanied by septic shock, disseminated intravascular coagulation and multiple organ failure. Often a rapid progression of the disease, with an 8-15% case-fatality ratio. This may result in death within one or two days after onset of symptoms.
Epidemiology
In 2018, 3,233 confirmed cases of invasive meningococcal disease (IMD), including 324 deaths, were reported in 30 EU/EEA Member States.
Explosive epidemics with incidence rates of up to 1,000 cases per 100,000 inhabitants have been reported, particularly in sub-Saharan Africa.
Vaccines Pipeline
the pipeline
TECHNOLOGY PLATFORMS
Glycoconjugate vaccine (2)
DEVELOPMENT PHASES
Phase III (1)
Under review (1)
TRIAL POPULATION
Paediatric (2)
Vaccines Pipeline
the pipeline
TECHNOLOGY PLATFORMS
Protein subunit (1)
DEVELOPMENT PHASES
Phase II (1)
TRIAL POPULATION
Paediatric + Adults + Older Adults (1)
Vaccines Pipeline
the pipeline
TECHNOLOGY PLATFORMS
Protein subunit (1)
Multiple platforms (3)Phase II (2)
Phase III (2)
DEVELOPMENT PHASES
Phase II (2)
Phase III (2)
TRIAL POPULATION
Paediatric (2)
Paediatric + Adults (1)
N/A (1)
Source:
WHO. Meningococcal meningitis. [cited 2023 August]. Available from: https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/vaccine-standardization/meningococcal-meningitis.
ECDC. Meningococcal disease. [cited 2023 August]. Available from: https://www.ecdc.europa.eu/en/meningococcal-disease.
ECDC. Invasive meningococcal disease. Annual Epidemiological Report for 2018. 2018 [cited 2023 August]. Available from: https://www.ecdc. europa.eu/sites/default/files/documents/AER-Invasive-meningococcal-disease-2018.pdf.
Purmohamad A et al. Microb Pathog 2019;134:103571